The KAS group currently works in three research directions:
Synthetic nucleoside analogues and oligonucleotide probes for in vitro studies of nucleic acid interactions and diagnostics run by Christian Oettinger and Justas Mikutavicius.
Therapeutic bioconjugates and delivery methods for treatment of infectious and autoimmune diseases carried out by Emilie S Lassen and Adrian H Bustos
Fundamental studies of molecular origins of cancer and autoimmune diseases carried out by Adrian H Bustos
Our studies are supported by National Institutes for Health, USA, R pharm and DTU Proof of Concept grant.